We report on two cases of women on trastuzumab therapy for breast cancer who became pregnant and delivered healthy live infants. At the time of reporting the children are growing and developing normally (ages 3 and 2)

Goodyer, Matthew J

Hughes, Paul AF

Ismail, Jeffri RM

Moylan, Eugene J

O'Connor, Alan

O'Reilly, Seamus P

Ryan, C Anthony M

CiteSeerX

Crossref

Springer - Publisher Connector

PubMed Central

English

Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn. Clin Gastroenterol Hepatol

Collichio FA, Dees EC: Concomitant pregnancy and breast cancer: options for systemic therapy. Breast Disease

E: Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy. Lancet Oncology

Effect of adjuvant trastuzumab on pregnancy.

Favorable pregnancy outcome following trastuzumab (Herceptin) use during pregnancy--Case report and updated literature review. Reproductive toxicology

Herceptin (trastuzumab) therapy during pregnancy: association with reversible anhydramnios. Obstetrics and Gynecology

Herceptin Prescribing Information.

Placental transport of immunoglobulin G. Vaccine

PR: Trastuzumab use for metastatic breast cancer in pregnancy. Obstetrics and Gynecology

RD: Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

Shapiro CL: Treatment of breast cancer with trastuzumab during pregnancy.

The effects of rituximab treatment during pregnancy on a neonate. Haematologica

Trastuzumab in pregnancy associated with poor fetal outcome. Annals of Oncology

Safety of trastuzumab (Herceptin®) during pregnancy: two case reports